Other
Granted (in shares)
Year-over-year, this metric declined by 0.5%, from $129.67 to $128.98. Over 4 years (FY 2021 to FY 2025), Granted (in shares) shows an upward trend with a 6.0% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026Apr 28, 2026
How to read this metric
Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.
Detailed definition
This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...
Peer comparison
Standard disclosure for companies with active equity compensation programs.
Metric ID:
other_share_based_compensation_arrangements_by_share_bas_099e66Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.08 | $0.30 | $0.00 | $86.76 | $0.00 | $0.00 | $0.96 | $101.09 | -$62.96 | $0.00 | $0.00 | $127.94 | $0.00 | $0.00 | $0.72 | $129.67 | -$0.03 | $0.11 | $0.00 | $128.98 |
| QoQ Change | — | +275.0% | -100.0% | — | -100.0% | — | — | >999% | -162.3% | +100.0% | — | — | -100.0% | — | — | >999% | -100.0% | +466.7% | -100.0% | — |
| YoY Change | — | — | — | — | -100.0% | -100.0% | — | +16.5% | — | — | -100.0% | +26.6% | +100.0% | — | — | +1.4% | — | — | -100.0% | -0.5% |
Range-$62.96 – $129.67
CAGR+373.4%
Avg YoY Growth-28.5%
Median YoY Growth-0.5%
Current Streak2 quarters decline
Granted (in shares) at Other Companies
Frequently Asked Questions
- What is Xylem's granted (in shares)?
- Xylem (XYL) reported granted (in shares) of $128.98 in Q1 2026.
- How has Xylem's granted (in shares) changed year-over-year?
- Xylem's granted (in shares) decreased by 0.5% year-over-year, from $129.67 to $128.98.
- What is the long-term trend for Xylem's granted (in shares)?
- Over 4 years (2021 to 2025), Xylem's granted (in shares) has grown at a 6.0% compound annual growth rate (CAGR), from $102.61 to $129.75.
- What does granted (in shares) mean?
- The total number of shares issued or granted under specific equity compensation plans.